Learning

A federal jury in Connecticut convicted a Russian national on Tuesday for operating a “crypting” service used to conceal “Kelihos” malware from antivirus software, enabling hackers to systematically infect victim computers around the world with malicious software, including ransomware. “By operating a website that was intended to hide malware from antivirus programs, Koshkin provided a critical service that enabled other cyber criminals to infect thousands of computers around the world,” said Acting U.S. Attorney Leonard C. Boyle for the District of Connecticut. “We will investigate and prosecute the individuals who aid and abet cyber criminals as vigorously as we do the ones who actually hit the ‘send’ button on viruses and other malicious software.”  more »

Jo Freeman writes: If you enjoyed listening to Elizabeth Warren during the 2019/20 Presidential debates or if you applauded her on the campaign trail, you will love this book. It’s one very long campaign speech. In six chapters she entertains readers with stories of her youth, her family, her dog, her plans, her policy proposals, and a few insights... Not until the final chapter on being “A Woman” does she begin to tie her experiences together. She ran into a lot of glass ceilings and broke some of them, but never escaped the “discrimination that lasts a lifetime.” She talks about care giving and abortion, as well as the consequences of unequal pay and limited job opportunities for women... As her final story, Warren writes about a little girl she met on the selfie line in St. Paul Minnesota, in 2019. That girl told her “You better win... I’ve been waiting for a girl president since.... since... since kindergarten.” more »

Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease. The candidate showed 100% protection against moderate and severe disease. In people at high risk of developing complications from COVID-19 (people 65 years or older and people under age 65 with certain comorbidities or with likely regular exposure to COVID-19), the vaccine showed 91.0% efficacy in preventing symptomatic COVID-19 disease. more »

"The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S.— and now we’re about to find out. After a nearly 20-year dry spell in new treatments for Alzheimer’s disease, the Food and Drug Administration (FDA) just approved a new Alzheimer’s medication, Aduhelm (aducanumab), developed by Biogen, with an expected annual price tag of $56,000. While the scientific community debates the evidence of the effectiveness of this new drug, the FDA’s decision raises hope for Alzheimer’s patients and their families, along with serious cost concerns for patients and payers, particularly Medicare." more »